Mr Mrs Miss Ms Dr Other

Dr
David
Selby

Partner & Patent Attorney

Leeds Office Manchester Office

Chemistry

Telephone. +44(0) 113 233 0100
Mobile. +44(0) 758 599 7412
Email. [email protected]
UPC Representative
Our team of specialist European patent litigators, oppositions specialists and patent attorneys bring together an extensive depth of legal and technical knowledge and are qualified to represent you in the UPC.

Experience

David's practice is predominantly in the areas of chemical and biomedical research tools, analytical instrumentation, pharmaceuticals, and cell culture technologies. David's experience in these areas includes GB and European patent prosecution, drafting and international portfolio management for large corporations, universities and spin-out companies. David also has significant experience in oppositions and appeals before the EPO. Other subject matter that falls within David's practice includes medical devices, nanotechnology and advanced materials.

David has a PhD in Chemistry, as well as a law degree from the University of New South Wales. His research experience included the construction of a novel mass spectrometer, and the application of mass spectrometry to proteomics and analysis of post-translational modification of proteins. His research experience thus covers development of instrumentation and methods of chemical analysis, through to characterisation of biological materials.

David qualified as a solicitor in Sydney, Australia, where he worked in IP litigation and has also qualified as a solicitor in England and Wales. David's practice draws on this combination of scientific and legal experience, with his understanding of enforcement and opposition informing his patent drafting and prosecution, and assisting David in providing commercially focused strategic advice in all areas of his practice.

Qualifications

Patent Attorney

Chartered (UK)
Europe


BSC

BSc in Chemistry with Hons 1

LLB

Bachelors of laws, UNSW

PHD

Chemistry

Publications

HGF continues to grow with 7 new promotions

View publication online

Conferences: 2024

October 15th 2024

Targeting protein degradation 4

Attending

Event details

CSR

David is a member of the Sustainability Focus Group at HGF which helps to promote sustainability at HGF

Related News

Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Successful patent protection in Europe - from application to protection

HGF is pleased to invite you to our upcoming German-language seminar on “Successful patent protection in Europe – from application to defence in Salzburg and Dresden. The seminar provides participants …

Event details
Event - 10th October 2024

Webinar: Patents and business activities in harmony

In today’s highly competitive world, patents are not only a legal tool but also a strategic instrument to strengthen your market position and maximise your business success. But how do …

Event details
Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Basics of trade mark protection - National and European perspectives

HGF is pleased to invite you to our upcoming German speaking seminar on “Fundamentals of trade mark protection: National and European Perspectives” in Salzburg and Dresden. The seminar will cover …

Event details

EPO Annual Fee Increases

The European Patent Office (EPO) has announced that revised Official Fees will apply to payments made on or after Monday 1st April 2024. The majority of fees will increase by …

Read article
Event - 30th January 2024

CAR-TCR Summit, Europe 2024

HGF are proud Event Partners of CAR-TCR Europe, which is due to go ahead from 27th – 29th February at ExCeL, Royal Victoria Dock in London. This is the European hub …

Event details

How to Use IP Strategy to Tip the Odds in Your Favour

Porter’s Five Forces model [1] is just one example of a convenient model for exploring and understanding the forces at play in a competitive marketplace. Michael Porter’s Five Forces model …

Read article

First CRISPR therapy approved for use in the UK

In an unprecedented move, the MHRA has approved a CRISPR gene editing therapy ‘Casgevy’  for the treatment of sickle cell disease and beta-thalassaemia in patients with recurrent vaso-occlusive crises. The Casgevy …

Read article
Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Invention and patent searches in public databases

HGF is pleased to invite you to our upcoming German-language seminar on “Invention and patent searches in public databases” in Salzburg and Dresden. The seminar will showcase how public databases …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.